Last Updated: Thursday, July 17, 2014, 15:10
Novartis is selling its animal health division to Eli Lilly for about USD 5.4 billion, in a deal it said on Thursday is now expected to close in the first quarter of 2015.
Last Updated: Tuesday, July 01, 2014, 15:16
In April, Novartis replaced the top executives at its Japanese arm over those allegations.
Last Updated: Friday, June 27, 2014, 09:39
Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.
Last Updated: Thursday, May 29, 2014, 04:32
Italy`s health ministry is seeking 1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported Wednesday.
Last Updated: Thursday, May 15, 2014, 09:40
Sun Pharma`s subsidiary holds a tentative approval from the U.S Food and Drug Administration for a generic version of Gleevec.
Last Updated: Thursday, April 24, 2014, 15:04
Swiss pharmaceuticals giant Novartis on Thursday posted a 24-percent jump in first-quarter net profit, driven largely by the sale of a blood transfusion diagnostics unit.
Last Updated: Wednesday, April 23, 2014, 10:54
Solid earnings and major pharmaceutical-sector deals lifted stocks Tuesday, producing a sixth straight day of gains for the S&P 500 and Nasdaq Composite Index.
Last Updated: Tuesday, April 22, 2014, 19:13
GlaxoSmithKline Consumer Healthcare shares closed at Rs 4,368 on the BSE, up 0.06 percent.
Last Updated: Tuesday, April 22, 2014, 19:10
UK-headquartered GSK will have majority control with an equity interest of 63.5 per cent in the venture.
Last Updated: Tuesday, April 22, 2014, 18:49
Shares of Novartis India on Tuesday surged 20 percent in intra-day as global pharma major Novartis will acquire GlaxoSmithKline plc's cancer drugs portfolio for USD 16 billion and sell its vaccines business in return for USD 7.1 billion.
Last Updated: Tuesday, April 22, 2014, 14:55
In Mumbai, Novartis India also climbed by 7.36 percent to 501.95 on BSE.
Last Updated: Tuesday, April 22, 2014, 14:24
Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly.
more videos >>